AI news impact · China A-shares
Dizal Pharmaceutical Co., Ltd. Class A (688192) news impact
On 2026-11-08 Wave Radar's AI rated the news on Dizal Pharmaceutical Co., Ltd. Class A as neutral (impact score 0%).
Media reported routine margin trading balance and daily financing changes for STAR Market stocks, including the company.
- Direction
- Neutral
- Impact score
- 0%
- Confidence
- 80%
- Headlines read
- 2
- Date
- 2026-11-08
AI assessment
The information reflects routine daily margin trading balance statistics rather than material operational changes, resulting in a neutral impact.
Sector impact
Routine market trading statistics with no material impact on the sector or supply chain.
Headlines the AI read
- 314只科创板股融资余额环比增加 AkShare/证券时报网 · 2026-11-06
- 科创板股融资融券余额每日变动(11月4日) AkShare/证券时报网 · 2026-11-05
More on Dizal Pharmaceutical Co., Ltd. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.